Results 201 to 210 of about 5,876,056 (368)
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
Molecular Oncology, EarlyView.mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia +17 more
wiley +1 more source
Light ternary fission products: probabilities and charge distributions. [Reviews, data systematics]
, 1977 D.G. Madland, L. Stewart
openalex +2 more sources
Efficacy of epidural steroid injections for low-back pain and sciatica: a systematic review of randomized clinical trials [PDF]
, 1995 Bart W. Koes +3 more
openalex +1 more source
Molecular Oncology, EarlyView.Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley +1 more source
Systematic review of near patient test evaluations in primary care [PDF]
, 1999 Brendan Delaney +8 more
openalex +1 more source
Molecular Oncology, EarlyView.MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin +14 more
wiley +1 more source
THE DRUG TREATMENT OF ALCOHOL WITHDRAWAL SYMPTOMS: A SYSTEMATIC REVIEW [PDF]
, 1998 Amanda C de C Williams, Andrew McBride
openalex +1 more source